Showing 1 - 10 of 678,315
Although personalized medicine is becoming the new paradigm to manage some diseases, the economics of personalized medicine have only focused on assessing the efficiency of specific treatments, lacking a theoretical framework analyzing the interactions between pharmaceutical firms and healthcare...
Persistent link: https://www.econbiz.de/10011586604
Persistent link: https://www.econbiz.de/10011999624
Persistent link: https://www.econbiz.de/10013384327
Constantly rising expenditures for pharmaceuticals require government intervention in firms' pricing decisions. To this … the introduction of a reference price leads to lower equilibrium prices and induces fiercer competition between firms …
Persistent link: https://www.econbiz.de/10011976973
Persistent link: https://www.econbiz.de/10011405945
-patent pharmaceuticals. We present a theoretical model with price-sensitive and loyal consumers that shows that a decrease in the reference … price affects the consumers' co-payments in a non-monotonic way: For high reference prices, a marginally lower reference … price may lead to lower co-payments. However, for low reference prices a further reduction may result into higher consumer …
Persistent link: https://www.econbiz.de/10010489291
Persistent link: https://www.econbiz.de/10010473653
Persistent link: https://www.econbiz.de/10010379568
Persistent link: https://www.econbiz.de/10014266816
Persistent link: https://www.econbiz.de/10012009099